Clinical Trial Update: A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the safety and effects of repeated doses of two broadly neutralizing antibodies, 3BNC117-LS and 10-1074-LS, on persistent HIV reser…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• 10-1074-LS (10-1074-LS)
• 3BNC117-LS (3BNC117-LS)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV-1 | Phase 1 | Status: ACTIVE_NOT_RECRUITING